Importantly, when we treated monocytes and ESCC cells co-cultures with spiroepoxide (exosome release inhibitor), there was a marked decrease in the percentage of PD1+macrophages (Fig. 3j). This evidence concerns the gene PDCD1 and esophageal squamous cell carcinoma.